Adv. Sci., 2019 · DOI: 10.1002/advs.201800808 · Published: February 27, 2019
MicroRNAs effectively modulate protein expression and cellular response. Unfortunately, the lack of robust nonviral delivery platforms has limited the therapeutic application of microRNAs. Here, a fiber substrate that provides nonviral delivery of microRNAs for in vitro and in vivo microRNA screening is introduced. As a proof of concept, difficult-to-transfect primary neurons are targeted and the efficacy of this system is evaluated in a rat spinal cord injury model. Altogether, the potential of the fiber platform is demonstrated in providing effective microRNA screening and direct translation into in vivo applications.
The biomimicking aligned fiber platform enables sustained and nonviral delivery of microRNAs (miRs) both in vitro and in vivo, addressing a significant bottleneck in miR therapy.
Incorporating miRs into biomimicking PCL fiber constructs enhances gene silencing and promotes nerve regeneration, offering a promising approach for treating spinal cord injuries.
The fiber-mediated miR delivery platform serves as an effective in vitro and in vivo drug testing system, facilitating the development of miR therapeutics for tissue regeneration.